S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in
NASDAQ:BIOL

BIOLASE SEC Filings & 10K Form

$0.91
-0.01 (-1.09 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.89
Now: $0.91
$0.99
50-Day Range
$0.53
MA: $1.06
$1.50
52-Week Range
$0.21
Now: $0.91
$1.51
Volume7.87 million shs
Average Volume45.48 million shs
Market Capitalization$132.43 million
P/E RatioN/A
Dividend YieldN/A
Beta1.98

SEC Filings

BIOLASE (NASDAQ:BIOL) SEC Filings

DateFilerForm TypeView
02/23/2021
6:33 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
1:52 PM
ARMISTICE CAPITAL, LLC (Filed by)
BIOLASE (Subject)
Form SC 13G/A
02/09/2021
4:00 PM
BIOLASE (Filer)
Form 424B5
02/04/2021
4:15 PM
BIOLASE (Filer)
Form DEFA14A
02/04/2021
4:13 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2021
4:13 PM
BIOLASE (Subject)
FEINBERG LARRY N (Filed by)
Form SC 13D/A
02/03/2021
5:02 AM
BIOLASE (Filer)
Form DEFA14A
02/01/2021
5:06 AM
BIOLASE (Filer)
Form DEFA14A
01/29/2021
5:34 AM
BIOLASE (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
Form SC 13G/A
01/26/2021
5:04 AM
BIOLASE (Filer)
Form DEFR14A
01/22/2021
3:22 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2020
10:47 AM
BIOLASE (Filer)
Form 424B3
12/13/2020
11:17 PM
BIOLASE (Filer)
Form EFFECT
12/11/2020
5:09 AM
BIOLASE (Filer)
Form DEF 14A
12/08/2020
5:06 AM
BIOLASE (Filer)
Form S-1/A
11/27/2020
10:15 AM
BIOLASE (Filer)
Form PRE 14A
11/13/2020
4:26 PM
BIOLASE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2020
3:05 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2020
12:43 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2020
9:12 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
3:05 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2020
12:44 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
5:37 PM
BEAVER JOHN R (Reporting)
BIOLASE (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
5:32 PM
BIOLASE (Issuer)
Norbe Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
8:51 AM
BIOLASE (Issuer)
LORD JONATHAN T MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2020
8:49 AM
BIOLASE (Issuer)
DiTolla Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2020
5:40 PM
BIOLASE (Issuer)
LORD JONATHAN T MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2020
5:32 PM
BIOLASE (Issuer)
Norbe Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2020
4:40 PM
BEAVER JOHN R (Reporting)
BIOLASE (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2020
4:16 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2020
4:13 PM
BIOLASE (Filer)
Form 424B4
07/15/2020
4:17 PM
BIOLASE (Filer)
Form S-1MEF
07/01/2020
11:00 PM
BIOLASE (Filer)
Form EFFECT
07/01/2020
4:28 PM
BIOLASE (Filer)
Form 424B4
06/26/2020
4:25 PM
BIOLASE (Filer)
Form S-1/A
06/12/2020
2:14 PM
BIOLASE (Filer)
Form D
Notice of Exempt Offering of Securities 
06/10/2020
4:05 PM
BIOLASE (Issuer)
FEINBERG LARRY N (Reporting)
ORACLE PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2020
4:25 PM
BIOLASE (Filer)
Form 424B5
06/09/2020
8:02 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2020
4:00 PM
BIOLASE (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/01/2020
3:30 PM
BIOLASE (Filer)
Form SD
Specialized Disclosure Report  
05/28/2020
4:22 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2020
11:09 AM
BIOLASE (Issuer)
Norbe Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
11:08 AM
BEAVER JOHN R (Reporting)
BIOLASE (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
11:05 AM
BIOLASE (Issuer)
Wagner Elaine C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
11:04 AM
BIOLASE (Issuer)
Sato Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
11:04 AM
BIOLASE (Issuer)
DiTolla Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
11:03 AM
BIOLASE (Issuer)
Lanman Richard B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
11:02 AM
BIOLASE (Issuer)
ROPER JESS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
10:46 AM
BIOLASE (Issuer)
LORD JONATHAN T MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2020
10:31 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2020
11:31 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2020
2:11 PM
BIOLASE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/13/2020
5:03 AM
BIOLASE (Filer)
Form PRE 14A
04/08/2020
3:21 PM
BIOLASE (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G/A
04/06/2020
2:16 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2020
5:08 AM
BIOLASE (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2020
3:23 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2020
4:29 PM
Archon Capital Management LLC (Filed by)
BIOLASE (Subject)
Form SC 13G/A
12/06/2019
3:31 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
3:26 PM
BIOLASE (Issuer)
DiTolla Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/19/2019
8:13 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
3:10 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2019
12:26 PM
BIOLASE (Filer)
Form D
Notice of Exempt Offering of Securities 
11/04/2019
4:23 PM
BIOLASE (Subject)
FEINBERG LARRY N (Filed by)
Form SC 13D/A
11/01/2019
5:30 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
8:21 PM
BIOLASE (Issuer)
FEINBERG LARRY N (Reporting)
ORACLE PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
4:19 PM
BIOLASE (Filer)
Form 424B4
10/25/2019
5:32 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2019
11:15 PM
BIOLASE (Filer)
Form EFFECT
10/21/2019
4:31 PM
BIOLASE (Filer)
Form S-1/A
10/21/2019
5:31 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2019
6:41 PM
BIOLASE (Subject)
Form FWP
10/04/2019
6:35 PM
BIOLASE (Filer)
Form S-1/A
10/04/2019
10:19 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2019
5:02 AM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2019
1:33 PM
BIOLASE (Issuer)
Norbe Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
3:33 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2019
11:15 PM
BIOLASE (Filer)
Form EFFECT
08/22/2019
5:45 PM
BIOLASE (Issuer)
Norbe Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
8:52 PM
BIOLASE (Issuer)
Norbe Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
2:01 PM
BIOLASE (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/09/2019
1:02 PM
BIOLASE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
12:42 PM
BIOLASE (Issuer)
Norbe Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
12:33 PM
BEAVER JOHN R (Reporting)
BIOLASE (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
10:02 AM
BIOLASE (Issuer)
Wagner Elaine C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
10:00 AM
BIOLASE (Issuer)
Sato Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
9:59 AM
BIOLASE (Issuer)
Lanman Richard B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
9:57 AM
BIOLASE (Issuer)
ROPER JESS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
9:54 AM
BIOLASE (Issuer)
LORD JONATHAN T MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:05 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
4:21 PM
BIOLASE (Subject)
FEINBERG LARRY N (Filed by)
Form SC 13D/A
06/27/2019
3:31 PM
BIOLASE (Issuer)
FEINBERG LARRY N (Reporting)
ORACLE PARTNERS LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
6:32 PM
BIOLASE (Issuer)
Norbe Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
4:18 PM
BIOLASE (Issuer)
Norbe Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
12:27 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
4:20 PM
BIOLASE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/10/2019
3:07 PM
BIOLASE (Filer)
Form DEF 14A
03/08/2019
11:33 AM
BIOLASE (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2019
3:05 PM
BIOLASE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.